News Search

Sadelain was elected for pioneering scientific studies that laid the groundwork for chimeric antigen receptor T cell (CAR-T) immunotherapy for cancer and for advancing its clinical application.

A peptide designed by Columbia researchers helps the immune system recognize and attack stomach cancer in mice and represents a promising new strategy for patients with gastric and other tumors.

Drugs already in development may have the potential to block the chemical and help people exposed to trauma in childhood, who do not often respond to SSRIs.

We asked our neuroscientists, they responded: Understanding this extraordinary organ is key to understanding ourselves, tackling devastating diseases, and building a better future for us all.